References
- World Health Organisation. Global Tuberculosis Report 2014. Geneva, Switzerland: WHO. 2014. Google Scholar
- ONUSIDA. Fiche d’information 2015. Accessed on 20 April 2017
- Pawlowski A, Jansson M, Sköld M, Rottenberg ME, Källenius G. Tuberculosis and HIV co-infection. PLoS Pathog. 2012; 8(2): e1002464. PubMed | Google Scholar
- Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo
DM, Dilektasli AG et al, TBNET. Risk assessment of
tuberculosis in immunocompromised patients. A TBNET study. Am J Respir
Crit Care Med. 2014 Nov 15; 190(10):
1168-76. PubMed | Google
Scholar
- Matabane MMZ, Ismail F, Strydom AK, Onwuegbuna O, Omar SV, Ismail N. Performance evaluation of three commercial molecular assays for the detection of Mycobacterium tuberculosis from clinical specimens in a high TB-HIV burden setting. BMC Infect Dis. 2015; 15: 508. PubMed | Google Scholar
- Blakemore R, Story E, Helb D, Kop J, Banada P, Owens MR et al. Evaluation of the analytical performance of the Xpert MTB/RIF Assay. J Clin Microbiol. 2010; 48(7): 2495-501. PubMed | Google Scholar
- Kaswa MK, Bisuta S, Kabuya G, Lunguya O, Ndongosieme A, Muyembe JJ et al. Multi Drug Resistant Tuberculosis in Mosango, a Rural Area in the Democratic Republic of Congo. PLoS One. 2014; 9(4): e94618. PubMed | Google Scholar
- Gounder A, Gounder S, Reid SA. Evaluation of the implementation of the Xpert® MTB/RIF assay in Fiji. Public Health Action. 2014; 4(3): 179-183. PubMed | Google Scholar
- Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of the GeneXpert MTB/RIF Assay for rapid diagnosis of tuberculosis and detection of Rifampin Resistance in pulmonary and extra pulmonary specimens. J Clin Microbiol. 2011; 49(12): 4138-4141. PubMed | Google Scholar
- Sekadde MP, Wobudeya E, Joloba ML, Ssengooba W, Kisembo H, Bakeera-Kitaka S et al. Evaluation of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis in Uganda: a cross-sectional diagnostic study. BMC Infect Dis. 2013 Mar 12; 13: 133. PubMed | Google Scholar
- Geleta DA, Megerssa YC, Gudeta AN, Akalu GT, Debele MT, Tulu KD. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility. BMC Microbiol. 2015 Oct 19; 15: 220. PubMed | Google Scholar
- Giang DC, Duong TN, Minh Ha DT, Nhan HT, Wolbers M, Nhu NT et al. Prospective evaluation of GeneXpert MTB/Rif for the diagnosis of HIV- negative pediatric TB cases. BMC Infect Dis. 2015; 15: 70. PubMed | Google Scholar
- Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M et al. Screening for HIV-associated Tuberculosis
and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert
MTB/RIF Assay:
a prospective Study. PLoS Med. 2011; 8(7): e1001067. PubMed | Google
Scholar
- Carniel F, Dalla Costa ER, Lima-Bello G, Martins C, Scherer LC, Rossetti ML. Use of conventional PCR and smear microscopy to diagnose pulmonary tuberculosis in the Amazonian rainforest area. Braz J Med Biol Res. 2014; 47(12): 1016-20. PubMed | Google Scholar
- Hanrahan CF, Theron G, Bassett J, Dheda K, Scott L, Stevens W et al. Xpert MTB/RIF as a Measure of Sputum Bacillary Burden Variation by HIV Status and Immunosuppression. Am J Respir Crit Care Med. 2014; 189(11): 1426-34. PubMed | Google Scholar
- Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014 Jan 21; (1): CD009593. PubMed | Google Scholar
- Sanchez-Padilla E, Merker M, Beckert P, Jochims F, Dlamini T, Kahn P et al. Detection of Drug-Resistant tuberculosis by Xpert MTB/RIF in Swaziland. N Engl J Med. 2015; 372(12): 1181-2. PubMed | Google Scholar